During a system upgrade from Friday, Dec. 5, through Sunday, Dec. 7, the AAFP website, on-demand courses and CME purchases will be unavailable.

brand logo

Am Fam Physician. 2023;107(6):online

Clinical Question

How effective is the eradication of Helicobacter pylori for the treatment of functional dyspepsia?

Bottom Line

H. pylori eradication is an effective treatment for cure or improvement of functional dyspepsia symptoms, especially if there is evidence of successful H. pylori eradication. (Level of Evidence = 1a)

Synopsis

The systematic review updated a previous Cochrane review with 10 new trials and 2,896 patients, for a total of 29 trials and 6,781 patients. The authors did a high-quality systematic review to identify randomized trials with at least three months of follow-up, using a random effects meta-analysis. Only six studies were classified as having a low risk of bias, and the most common problems were unclear allocation concealment and unclear complete outcome reporting. Based on 18 studies with 4,564 patients, H. pylori eradication therapy decreased the likelihood of failure to cure functional dyspepsia (relative risk [RR] = 0.91; 95% CI, 0.88 to 0.94; I2 = 7%; number needed to treat [NNT] = 14). There was some evidence for publication bias, suggesting that smaller, negative trials were not published. The benefit was consistent regardless of the comparator (i.e., placebo or antisecretory therapy) or study quality. Based on 22 studies with 5,193 patients, H. pylori eradication therapy decreased the likelihood of failure to improve symptoms, without evidence of publication bias but with moderate heterogeneity (RR = 0.84; 95% CI, 0.78 to 0.91; I2 = 69%; NNT = 9). Sixteen studies reported whether eradication was successful, and patients with successful eradication were significantly less likely to fail to improve or fail to be cured than those who received the comparator (RR = 0.74; 95% CI, 0.64 to 0.85; I2 = 82%; NNT = 6). There was significant heterogeneity, and funnel plot asymmetry suggests possible publication bias.

Study design: Meta-analysis (randomized controlled trials)

Funding source: Self-funded or unfunded

Setting: Outpatient (any)

Reference: Ford AC, Tsipotis E, Yuan Y, et al. Efficacy of Helicobacter pylori eradication therapy for functional dyspepsia: updated systematic review and meta-analysis. Gut. 2022;71(10):1967-1975.

Editor's Note: Dr. Ebell is deputy editor for evidence-based medicine for AFP and cofounder and editor-in-chief of Essential Evidence Plus, published by Wiley-Blackwell.

POEMs (patient-oriented evidence that matters) are provided by Essential Evidence Plus, a point-of-care clinical decision support system published by Wiley-Blackwell. For more information, see http://www.essentialevidenceplus.com. Copyright Wiley-Blackwell. Used with permission.

For definitions of levels of evidence used in POEMs, see https://www.essentialevidenceplus.com/Home/Loe?show=Sort.

Primary Care Update, a free podcast focused on POEMs, is available on Apple Podcasts and Spotify.

This series is coordinated by Natasha J. Pyzocha, DO, contributing editor.

A collection of POEMs published in AFP is available at https://www.aafp.org/afp/poems.

Continue Reading


More in AFP

More in PubMed

Copyright © 2023 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.